New Cytokines as Potential Drugs:
Over the past ten years, a number of cytokines and growth factors have proven to be as effective therapeutics. While these products have certainly established recombinant biologics as a major pharmaceutical growth sector, the continued interest in this class of drugs arises from the fact that today...
Gespeichert in:
Weitere Verfasser: | , |
---|---|
Format: | Elektronisch E-Book |
Sprache: | English |
Veröffentlicht: |
Basel
Birkhäuser Basel
2000
|
Schriftenreihe: | Progress in Inflammation Research
|
Schlagworte: | |
Online-Zugang: | UBR01 Volltext |
Zusammenfassung: | Over the past ten years, a number of cytokines and growth factors have proven to be as effective therapeutics. While these products have certainly established recombinant biologics as a major pharmaceutical growth sector, the continued interest in this class of drugs arises from the fact that today we have a far better understanding of the human immune response, both at a cellular and molecular level. This has resulted in a more methodical characterisation of these factors which has given clinical researchers an opportunity to plan Phase 1 clinical trials that can provide substantial information on the activity of the cytokine in humans. Currently, a great deal of effort is also being channelled into identifying cytokines from the various DNA databases. Our major objective for this book is to profile cytokines that have been recently identified. The therapeutic potential of these cytokines based on their known properties will be discussed by the authors. The main aim of this book is to provide.. |
Beschreibung: | 1 Online-Ressource (XI, 141 p) |
ISBN: | 9783034884563 |
DOI: | 10.1007/978-3-0348-8456-3 |
Internformat
MARC
LEADER | 00000nmm a2200000zc 4500 | ||
---|---|---|---|
001 | BV046147079 | ||
003 | DE-604 | ||
005 | 00000000000000.0 | ||
007 | cr|uuu---uuuuu | ||
008 | 190905s2000 |||| o||u| ||||||eng d | ||
020 | |a 9783034884563 |9 978-3-0348-8456-3 | ||
024 | 7 | |a 10.1007/978-3-0348-8456-3 |2 doi | |
035 | |a (ZDB-2-SME)978-3-0348-8456-3 | ||
035 | |a (OCoLC)1119082432 | ||
035 | |a (DE-599)BVBBV046147079 | ||
040 | |a DE-604 |b ger |e aacr | ||
041 | 0 | |a eng | |
049 | |a DE-355 | ||
082 | 0 | |a 616 |2 23 | |
084 | |a XD 3215 |0 (DE-625)152553:12921 |2 rvk | ||
245 | 1 | 0 | |a New Cytokines as Potential Drugs |c edited by Satwant K. Narula, Robert Coffman |
264 | 1 | |a Basel |b Birkhäuser Basel |c 2000 | |
300 | |a 1 Online-Ressource (XI, 141 p) | ||
336 | |b txt |2 rdacontent | ||
337 | |b c |2 rdamedia | ||
338 | |b cr |2 rdacarrier | ||
490 | 0 | |a Progress in Inflammation Research | |
520 | |a Over the past ten years, a number of cytokines and growth factors have proven to be as effective therapeutics. While these products have certainly established recombinant biologics as a major pharmaceutical growth sector, the continued interest in this class of drugs arises from the fact that today we have a far better understanding of the human immune response, both at a cellular and molecular level. This has resulted in a more methodical characterisation of these factors which has given clinical researchers an opportunity to plan Phase 1 clinical trials that can provide substantial information on the activity of the cytokine in humans. Currently, a great deal of effort is also being channelled into identifying cytokines from the various DNA databases. Our major objective for this book is to profile cytokines that have been recently identified. The therapeutic potential of these cytokines based on their known properties will be discussed by the authors. The main aim of this book is to provide.. | ||
650 | 4 | |a Internal Medicine | |
650 | 4 | |a Biomedicine general | |
650 | 4 | |a Immunology | |
650 | 4 | |a Internal medicine | |
650 | 4 | |a Medicine | |
650 | 4 | |a Immunology | |
650 | 0 | 7 | |a Pharmakotherapie |0 (DE-588)4076066-2 |2 gnd |9 rswk-swf |
650 | 0 | 7 | |a Cytokine |0 (DE-588)4205701-2 |2 gnd |9 rswk-swf |
655 | 7 | |0 (DE-588)4143413-4 |a Aufsatzsammlung |2 gnd-content | |
689 | 0 | 0 | |a Cytokine |0 (DE-588)4205701-2 |D s |
689 | 0 | 1 | |a Pharmakotherapie |0 (DE-588)4076066-2 |D s |
689 | 0 | |5 DE-604 | |
700 | 1 | |a Narula, Satwant K. |4 edt | |
700 | 1 | |a Coffman, Robert |4 edt | |
776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe |z 9783034895750 |
776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe |z 9783764358839 |
776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe |z 9783034884570 |
856 | 4 | 0 | |u https://doi.org/10.1007/978-3-0348-8456-3 |x Verlag |z URL des Erstveröffentlichers |3 Volltext |
912 | |a ZDB-2-SME | ||
940 | 1 | |q ZDB-2-SME_1990/2004 | |
999 | |a oai:aleph.bib-bvb.de:BVB01-031527264 | ||
966 | e | |u https://doi.org/10.1007/978-3-0348-8456-3 |l UBR01 |p ZDB-2-SME |q ZDB-2-SME_1990/2004 |x Verlag |3 Volltext |
Datensatz im Suchindex
_version_ | 1804180485941755904 |
---|---|
any_adam_object | |
author2 | Narula, Satwant K. Coffman, Robert |
author2_role | edt edt |
author2_variant | s k n sk skn r c rc |
author_facet | Narula, Satwant K. Coffman, Robert |
building | Verbundindex |
bvnumber | BV046147079 |
classification_rvk | XD 3215 |
collection | ZDB-2-SME |
ctrlnum | (ZDB-2-SME)978-3-0348-8456-3 (OCoLC)1119082432 (DE-599)BVBBV046147079 |
dewey-full | 616 |
dewey-hundreds | 600 - Technology (Applied sciences) |
dewey-ones | 616 - Diseases |
dewey-raw | 616 |
dewey-search | 616 |
dewey-sort | 3616 |
dewey-tens | 610 - Medicine and health |
discipline | Medizin |
doi_str_mv | 10.1007/978-3-0348-8456-3 |
format | Electronic eBook |
fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>03007nmm a2200565zc 4500</leader><controlfield tag="001">BV046147079</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">00000000000000.0</controlfield><controlfield tag="007">cr|uuu---uuuuu</controlfield><controlfield tag="008">190905s2000 |||| o||u| ||||||eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9783034884563</subfield><subfield code="9">978-3-0348-8456-3</subfield></datafield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1007/978-3-0348-8456-3</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ZDB-2-SME)978-3-0348-8456-3</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)1119082432</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV046147079</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">aacr</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-355</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">616</subfield><subfield code="2">23</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">XD 3215</subfield><subfield code="0">(DE-625)152553:12921</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">New Cytokines as Potential Drugs</subfield><subfield code="c">edited by Satwant K. Narula, Robert Coffman</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Basel</subfield><subfield code="b">Birkhäuser Basel</subfield><subfield code="c">2000</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 Online-Ressource (XI, 141 p)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="0" ind2=" "><subfield code="a">Progress in Inflammation Research</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Over the past ten years, a number of cytokines and growth factors have proven to be as effective therapeutics. While these products have certainly established recombinant biologics as a major pharmaceutical growth sector, the continued interest in this class of drugs arises from the fact that today we have a far better understanding of the human immune response, both at a cellular and molecular level. This has resulted in a more methodical characterisation of these factors which has given clinical researchers an opportunity to plan Phase 1 clinical trials that can provide substantial information on the activity of the cytokine in humans. Currently, a great deal of effort is also being channelled into identifying cytokines from the various DNA databases. Our major objective for this book is to profile cytokines that have been recently identified. The therapeutic potential of these cytokines based on their known properties will be discussed by the authors. The main aim of this book is to provide..</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Internal Medicine</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Biomedicine general</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Immunology</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Internal medicine</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Medicine</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Immunology</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Pharmakotherapie</subfield><subfield code="0">(DE-588)4076066-2</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Cytokine</subfield><subfield code="0">(DE-588)4205701-2</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="0">(DE-588)4143413-4</subfield><subfield code="a">Aufsatzsammlung</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Cytokine</subfield><subfield code="0">(DE-588)4205701-2</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Pharmakotherapie</subfield><subfield code="0">(DE-588)4076066-2</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Narula, Satwant K.</subfield><subfield code="4">edt</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Coffman, Robert</subfield><subfield code="4">edt</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druck-Ausgabe</subfield><subfield code="z">9783034895750</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druck-Ausgabe</subfield><subfield code="z">9783764358839</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druck-Ausgabe</subfield><subfield code="z">9783034884570</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1007/978-3-0348-8456-3</subfield><subfield code="x">Verlag</subfield><subfield code="z">URL des Erstveröffentlichers</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-2-SME</subfield></datafield><datafield tag="940" ind1="1" ind2=" "><subfield code="q">ZDB-2-SME_1990/2004</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-031527264</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">https://doi.org/10.1007/978-3-0348-8456-3</subfield><subfield code="l">UBR01</subfield><subfield code="p">ZDB-2-SME</subfield><subfield code="q">ZDB-2-SME_1990/2004</subfield><subfield code="x">Verlag</subfield><subfield code="3">Volltext</subfield></datafield></record></collection> |
genre | (DE-588)4143413-4 Aufsatzsammlung gnd-content |
genre_facet | Aufsatzsammlung |
id | DE-604.BV046147079 |
illustrated | Not Illustrated |
indexdate | 2024-07-10T08:36:31Z |
institution | BVB |
isbn | 9783034884563 |
language | English |
oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-031527264 |
oclc_num | 1119082432 |
open_access_boolean | |
owner | DE-355 DE-BY-UBR |
owner_facet | DE-355 DE-BY-UBR |
physical | 1 Online-Ressource (XI, 141 p) |
psigel | ZDB-2-SME ZDB-2-SME_1990/2004 ZDB-2-SME ZDB-2-SME_1990/2004 |
publishDate | 2000 |
publishDateSearch | 2000 |
publishDateSort | 2000 |
publisher | Birkhäuser Basel |
record_format | marc |
series2 | Progress in Inflammation Research |
spelling | New Cytokines as Potential Drugs edited by Satwant K. Narula, Robert Coffman Basel Birkhäuser Basel 2000 1 Online-Ressource (XI, 141 p) txt rdacontent c rdamedia cr rdacarrier Progress in Inflammation Research Over the past ten years, a number of cytokines and growth factors have proven to be as effective therapeutics. While these products have certainly established recombinant biologics as a major pharmaceutical growth sector, the continued interest in this class of drugs arises from the fact that today we have a far better understanding of the human immune response, both at a cellular and molecular level. This has resulted in a more methodical characterisation of these factors which has given clinical researchers an opportunity to plan Phase 1 clinical trials that can provide substantial information on the activity of the cytokine in humans. Currently, a great deal of effort is also being channelled into identifying cytokines from the various DNA databases. Our major objective for this book is to profile cytokines that have been recently identified. The therapeutic potential of these cytokines based on their known properties will be discussed by the authors. The main aim of this book is to provide.. Internal Medicine Biomedicine general Immunology Internal medicine Medicine Pharmakotherapie (DE-588)4076066-2 gnd rswk-swf Cytokine (DE-588)4205701-2 gnd rswk-swf (DE-588)4143413-4 Aufsatzsammlung gnd-content Cytokine (DE-588)4205701-2 s Pharmakotherapie (DE-588)4076066-2 s DE-604 Narula, Satwant K. edt Coffman, Robert edt Erscheint auch als Druck-Ausgabe 9783034895750 Erscheint auch als Druck-Ausgabe 9783764358839 Erscheint auch als Druck-Ausgabe 9783034884570 https://doi.org/10.1007/978-3-0348-8456-3 Verlag URL des Erstveröffentlichers Volltext |
spellingShingle | New Cytokines as Potential Drugs Internal Medicine Biomedicine general Immunology Internal medicine Medicine Pharmakotherapie (DE-588)4076066-2 gnd Cytokine (DE-588)4205701-2 gnd |
subject_GND | (DE-588)4076066-2 (DE-588)4205701-2 (DE-588)4143413-4 |
title | New Cytokines as Potential Drugs |
title_auth | New Cytokines as Potential Drugs |
title_exact_search | New Cytokines as Potential Drugs |
title_full | New Cytokines as Potential Drugs edited by Satwant K. Narula, Robert Coffman |
title_fullStr | New Cytokines as Potential Drugs edited by Satwant K. Narula, Robert Coffman |
title_full_unstemmed | New Cytokines as Potential Drugs edited by Satwant K. Narula, Robert Coffman |
title_short | New Cytokines as Potential Drugs |
title_sort | new cytokines as potential drugs |
topic | Internal Medicine Biomedicine general Immunology Internal medicine Medicine Pharmakotherapie (DE-588)4076066-2 gnd Cytokine (DE-588)4205701-2 gnd |
topic_facet | Internal Medicine Biomedicine general Immunology Internal medicine Medicine Pharmakotherapie Cytokine Aufsatzsammlung |
url | https://doi.org/10.1007/978-3-0348-8456-3 |
work_keys_str_mv | AT narulasatwantk newcytokinesaspotentialdrugs AT coffmanrobert newcytokinesaspotentialdrugs |